EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to the unmet clinical needs of millions of patients. Its innovative technologies are proven in clinical studies.
EyeYon Medical has created the market’s first ocular drug depot platform in the form of a non-invasive, comfortable, simple to use contact lens. The unique design of Hyper-CL™ Therapeutic Soft Contact Lens increases contact time and bioavailability of topical drops on the cornea. The lens’ special design enables capturing and maintaining any drop applied on its surface and may facilitate faster and better cornea healing. The advanced design of the lens was found to be clinically beneficial in the treatment of corneal edema and for a variety of indications that are being clinically tested. The Hyper-CL™ is CE approved, FDA 510(K) cleared, and is in commercialization stage in Europe, USA and India.
The newly developed concept is based on the patented technology and know-how of EyeYon Medical.
EyeYon’s future product is an Artificial Endothelial Layer – EndoArt® – a polymer film implant, which is attached to the posterior corneal surface, to treat corneal edema secondary to endothelial dysfunction. A non-functioning endothelium results in excess fluid flowing into the cornea, leading to corneal edema with severe vision loss. EndoArt® is a synthetic barrier to the excess fluid, designed to treat the corneal edema. The minimally invasive, suture-free EndoArt® implant is designed to replace the need for a human donor tissue, which is the current standard of care to resolve the edema. Both preclinical and early human clinical studies have demonstrated a significant reduction in edema in affected eyes.
Ofer is an inventor, entrepreneur and researcher, owner of several patents in the eye field. Ofer specialized in corneal and cataract surgery. Ofer is a senior cornea and cataract surgeon at Assuta Hashalom Medical Center.
Nahum is an entrepreneur who specializes in leading medical device projects from idea to a successful products. Nahum holds a B.Sc in Bio-medical Engineering and an MBA, both from Tel Aviv University.
Malca has over two decades of experience in the fields of regulatory affairs, preclinical research and clinical trials of medical devices and biotechnology, with an extensive experience working with ophthalmology products. Malca holds a Ph.D in Biology with highest distinction from Bar-Ilan University.
Dimitry has more than 13 years’ experience in the medical device industry, and has expertise in product development from device concept to marketplace. Dimitry holds a master's degree in Electro-Optical Engineering from Ben-Gurion University.
Oriah has experience in constructing experimental setups, carrying out laboratorial pre-clinical experiments and product development. She has background in the medical device industry and holds a Master's degree in Biomedical Engineering from Tel Aviv University.
Michal holds an LL.B, B.A (Econ) and an MBA (Marketing, Strategy & Entrepreneurship). She has 10 years of sales and marketing experience in the medical device industry, at Ethicon J&J and various startup companies.
Hagit has more than twelve years of experience in the medical device industry, and has expertise in the fields of project management, quality assurance and compliance. Hagit holds M.Sc in Biotechnology from The Hebrew University, Jerusalem.
Ronen is a graduate of the CIO Hi-Tech College. He has over 20 years of IT experience and over 15 years at the Pharma and Medical Device industry, small and medium size companies, at Colbar J&J and startup companies
Mali is a certified bookkeeper with over 8 years of office management, operation and bookkeeping experience with medical device companies in the commercial stage.
Anat has 15 years of experience in Optometry. She holds a degree in Optometry from Bar-Ilan University (B.Sc) and MBA from the Open University, experienced in professional consultancy in both private practice and hospital environment
Doyle is Director of Corneal Disease & Research at Woolfson Eye Institute. His career spans more than 30 years. Doyle chaired the Ophthalmic Devices Panel, an advisory group to the FDA, for three years and served as a member for ten. Doyle holds a B.Sc, MD, and PhD, all from Duke University.
Dr. Levy OD, MSc. has a long and distinguished career in the field of ophthalmology, a wide industry knowledge, skills and experience. He serves as a Clinical Professor in the Department of Ophthalmology at the University of Rochester's School of Medicine, and held several leading positions at Aerie Pharmaceuticals, Inc., Nexis Vision and Bausch + Lomb.
A founding partner and coordinator of the cornea, cataract and refractive surgery department of the IMO. The president of the European Society of Cornea and Ocular Surface Disease (EuCornea) and a member of the Editorial Board of Eurotimes Journal, Studium Ophthalmologicum and the Journal of Cataract and Refractive Surgery, and co-editor of the Consultation Section, EyeWorld Magazine since 2004.
Arie is a senior ophthalmic surgeon at the Kaplan Medical Center. Arie specialized in corneal surgery at the University of Toronto. He is former chairperson of the Israel Society of Cataract Surgeons and a guest lecturer in Israeli and international conferences. Arie is currently completing Ph.D studies for specialist MDs at the Weizmann Institute of Science, conducting research on corneal diseases.
Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He completed a fellowship in cornea and external disease at the University of Iowa, and then a second fellowship in ocular immunology at the National Eye Institute. He has an international reputation for his knowledge and expertise in the field of cornea and external disease.
Deputy director of the Department of Ophthalmology, Peking University, Third Hospital, Professor, Chief Physician, doctoral tutor, director of cornea ocular surface disease department, eye bank director, committee member of Chinese Ophthalmological Society Corneal Disease Group.
Prof Kim is Professor of Ophthalmology and serves as Chief of the Cornea and External Division and Director of the Refractive Surgery Service at Duke University Eye Center. Dr Kim Serves as the current president of the ASCRS.